William Jarnagin, Chief of Memorial Sloan Kettering’s Hepatopancreatobiliary Service, joins gastroenterologist Mark Schattner and gastrointestinal medical oncologist Eileen O’Reilly in a discussion about treatment developments for patients with pancreatic cancer. Medical journalist Dr. Max Gomez moderates the discussion and gives a brief overview of pancreatic cancer.
The panelists report that new diagnostic and surgical techniques, combined with more-effective approaches to chemotherapy and radiation therapy, have improved outcomes and quality of life for many people with this disease. Current research is aimed at providing patients with more therapeutic options, individualized chemotherapy regimens, and less-invasive treatments. The panelists emphasize the benefits of seeking care from a multidisciplinary team of experts who specialize in treating pancreatic cancer.